TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment

Table 2 The effects of TA-MSCs and TA-MSCs-EVs on tumors

Species	Cell source	Type of tumor	Effects on tumor	experimental type	Reference numbers
Human	GA-MSCs	Glioma	Promotion	In vitro and vivo	[48, 98]
Human	UC-MSCs	Liver cancer	Promotion	In vitro	[25]
Human	LC-MSCs	LC	Promotion	In vitro and vivo	[26, 37]
Human	BM-MSCs	PCa	Promotion	In vitro	[27]
Human	PCa-MSCs	PCa	Promotion	In vitro	[113]
Human	CRC-MSCs	CRC	Promotion	In vitro and vivo	[28, 65]
Human	BC-MSCs	BC	Promotion	In vitro	[30]
Human	CeCa-MSCs	CeCa	Promotion	In vitro	[36]
Human	GC-MSCs	GC	Promotion	In vitro and vivo	[39, 49, 79, 151, 167, 183, 204, 217, 218, 258]
Human	AML-MSCs	AML	Promotion	In vitro and vivo	[115, 165, 259, 260]
Human	CML-MSCs	CML	Promotion	In vitro	[40, 47]
Human	ALL-MSCs	ALL	Promotion	In vitro and vivo	[201]
Human	MM-MSCs	MM	Promotion	In vitro and vivo	[41, 66, 90, 91, 131]
Human	NB-MSCs	NB	Promotion	In vitro and vivo	[43]
Human	OC-MSCs	OC	Promotion	In vitro and vivo	[87, 96, 97, 174]
Human	BC-MSCs-EVs	BC	Promotion	In vitro and vivo	[122]
Human	MM-MSCs-EVs	MM	Promotion	In vitro and vivo	[90]
Human	ATRT-MSCs-EVs	ATRT	Promotion	In vitro and vivo	[45]
Human	OSCC-MSCs-EVs	OSCC	Promotion	In vitro	[46]
Human	CLL-MSCs-EVs	CLL	Promotion	In vitro	[67]
Mouse	BC-MSCs	BC	Promotion	In vitro and vivo	[184]
Mouse	MM-MSCs-EVs	MM	Promotion	In vitro and vivo	[91]

ISSN: 1479-5876